Activation of cytokines as a mechanism of disease progression in heart failure
暂无分享,去创建一个
[1] D. Mann,et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.
[2] T. LeJemtel,et al. Pathophysiological Correlates of Increased Serum Tumor Necrosis Factor in Patients With Congestive Heart Failure: Relation to Nitric Oxide‐Dependent Vasodilation in the Forearm Circulation , 1994, Circulation.
[3] J E Parrillo,et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.
[4] J. Kovacs,et al. The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.
[5] F. Pagani,et al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. , 1992, The Journal of clinical investigation.
[6] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[7] H. Cohen,et al. Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure. , 1995, Gerontology.
[8] J. Tavernier,et al. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.
[9] N. Takahashi,et al. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. , 1995, The Journal of clinical investigation.
[10] A. Oliff,et al. Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.
[11] AlbertSchömig,et al. Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction , 1995 .
[12] J. McMurray,et al. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.
[13] D. Mann,et al. Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .
[14] G. MacGowan,et al. Circulating interleukin-6 in severe heart failure. , 1997, The American journal of cardiology.
[15] T. LeJemtel,et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.
[16] D. Fukai,et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. , 1995, The American journal of cardiology.
[17] P. Ponikowski,et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.
[18] C. Lavie,et al. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. , 1996, Chest.
[19] J. A. Bowers,et al. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. , 1997, Journal of the American College of Cardiology.
[20] O. Febo,et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.
[21] G. Morris,et al. Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.
[22] L. Vaca,et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.
[23] H. Oral,et al. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. , 1997, Circulation research.
[24] A. Matsumori,et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.
[25] M. Singer,et al. TUMOUR NECROSIS FACTOR IN BRONCHOPULMONARY SECRETIONS OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME , 1989, The Lancet.
[26] H. Oral,et al. Tumor necrosis factor-alpha and the failing human heart. , 1995, Clinical cardiology.
[27] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.
[28] H. Oral,et al. Tumor necrosis factor-α and failing human heart , 1995 .
[29] A. Katz,et al. The failing heart: adaptation and deadaptation , 1983 .
[30] S Sasayama,et al. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. , 1994, Circulation.
[31] D. Hossfeld,et al. TNF-induced cardiomyopathy , 1990, The Lancet.
[32] P. Poole‐Wilson,et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. , 1997, The American journal of cardiology.
[33] Simon C Watkins,et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.
[34] M. Herold,et al. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. , 1993, Journal of the American College of Cardiology.
[35] M. Takemura,et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. , 1997, Journal of the American College of Cardiology.
[36] A. Ogata,et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. , 1995, Circulation.
[37] J. Lancaster,et al. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor , 1989, FEBS letters.
[38] M. Munger,et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1996, The American journal of cardiology.
[39] G. Schreiner,et al. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.
[40] D. Mann,et al. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.
[41] H. Dockrell. The Cytokine Handbook , 1993 .